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Summary
Background Active case-finding among contacts of patients with tuberculosis is a global health priority, but the effects 
of active versus passive case-finding are poorly characterised. We assessed the contribution of active versus passive 
case-finding to tuberculosis detection among contacts and compared sex and disease characteristics between contacts 
diagnosed through these strategies.
Methods In shanty towns in Callao, Peru, we identified index patients with tuberculosis and followed up contacts aged 
15 years or older for tuberculosis. All patients and contacts were offered free programmatic active case-finding entailing 
sputum smear microscopy and clinical assessment. Additionally, all contacts were offered intensified active case-finding 
with sputum smear and culture testing monthly for 6 months and then once every 4 years. Passive case-finding at local 
health facilities was ongoing throughout follow-up.
Findings Between Oct 23, 2002, and May 26, 2006, we identified 2666 contacts, who were followed up until 
March 1, 2016. Median follow-up was 10·0 years (IQR 7·5–11·0). 232 (9%) of 2666 contacts were diagnosed with 
tuberculosis. The 2-year cumulative risk of tuberculosis was 4·6% (95% CI 3·5–5·5), and overall incidence was 
0·98 cases (95% CI 0·86–1·10) per 100 person-years. 53 (23%) of 232 contacts with tuberculosis were diagnosed 
through active case-finding and 179 (77%) were identified through passive case-finding. During the first 6 months of 
the study, 23 (45%) of 51 contacts were diagnosed through active case-finding and 28 (55%) were identified through 
passive case-finding. Contacts diagnosed through active versus passive case-finding were more frequently female 
(36 [68%] of 53 vs 85 [47%] of 179; p=0·009), had a symptom duration of less than 15 days (nine [25%] of 36 vs ten [8%] 
of 127; p=0·03), and were more likely to be sputum smear-negative (33 [62%] of 53 vs 62 [35%] of 179; p=0·0003).
Interpretation Although active case-finding made an important contribution to tuberculosis detection among contacts, 
passive case-finding detected most of the tuberculosis burden. Compared with passive case-finding, active case-finding 
was equitable, helped to diagnose tuberculosis earlier and usually before a positive result on sputum smear 
microscopy, and showed a high burden of undetected tuberculosis among women.
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Biomedical Research Centre, Foundation for Innovative New Diagnostics, Sir Halley Stewart Trust, WHO, TB REACH, 
and IFHAD: Innovation for Health and Development.
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Introduction
Reducing tuberculosis transmission in households and 
communities entails early diagnosis of people living 
with tuberculosis followed by rapid initiation of appro­
priate treatment before tuberculosis becomes sputum 
smear­positive and more infectious.1 WHO estimates 
that, in 2017, more than a third of people living with 
tubercu losis were neither diagnosed, treated, nor 
reported, represen ting an enormous barrier to tubercu­
losis control and elimination.2 In most countries of low 
and middle income with a high burden of tuberculosis, 
investigation for tuberculosis usually only starts when 
people present to health services with symp toms 
suggestive of pulmon ary tuberculosis, termed passive 
case­finding. WHO recom mends that contacts of newly 
diagnosed patients are systematically screened because 
of their well­established high risk of disease.3,4 However, 
this active case­finding among contacts—termed con­
tact investi gation—is inconsist ently imple mented in 
settings with a high burden of tubercu losis, and evi­
dence to inform its opti mum delivery is scant.5
Most tuberculosis cases and deaths are reported in 
men.2 Analyses of prevalence surveys consolidate these 
case­notification data and show that overall tuberculosis 
prevalence is twice as high in men than in women.6 
However, these data are mostly from southeast Asia, 
Africa, and the western Pacific, with only two small 
subnational surveys in relatively isolated indigenous 
communities from Latin America contributing to the 
analysis. In Latin America, case notifications are consist­
ently higher in men and, in 2015, 61% of cases notified 
in Peru were reported in men.2,7 However, prevalence 
surveys of indigenous communities from Ecuador8 and 
Brazil9 imply a more equal tuberculosis prevalence by sex. 
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In previous work in Peru, we found tuberculosis 
diagnostic delay to be greater among women than men,10 
and qualitative research showed a common perception 
that women’s health and tuberculosis care was of 
secondary importance to that of men, hampering equit­
able access to health care.11 These observations support the 
hypothesis that the observed sex difference in tubercu losis 
notifications in Peru might be partly accounted for by 
underdetection of tuberculosis in women.
In this study, we investigated the long­term burden of 
tuberculosis in contacts of patients with tuberculosis, 
described the relative contribution of active and passive 
case­finding to tuberculosis case detection, and compared 
sex and disease characteristics between contacts 
diag nosed through active versus passive case­finding. 
These data characterise the epidemiology of tuberculosis 
among contacts in Peru, informing the optimum delivery 
of active case­finding among contacts that might be 
applic able in other countries of low and middle income, 
and provide important insights into the nature of sex 
differ ences in tuberculosis burden.
Methods
Participants
We did a prospective cohort study of contacts of index 
patients with tuberculosis from 16 desert shanty towns 
in Ventanilla, Callao, Peru. The study setting is fully 
described elsewhere in a detailed analysis of risk factors 
Research in context
Evidence before this study
We searched PubMed, Google Scholar, Web of Science, 
and Embase for studies published up to Oct 1, 2018, that 
investigated active case-finding among contacts of patients 
with tuberculosis. Search terms included, but were not 
restricted to, “tuberculosis”, “contact tracing”, “contact 
investigation”, “active case-finding”, “sex”, “prevalence”, and 
“passive case-finding”. We did not restrict this search by 
language. This search retrieved several observational studies 
describing active case-finding interventions and identified a 
large randomised controlled trial that showed the effectiveness 
of active case-finding for increasing case detection among 
contacts in a high-prevalence setting. However, few data 
described the relative contribution to the overall tuberculosis 
case burden of active versus passive case-finding among 
contacts over a prolonged period. Although active case-finding 
is generally considered to be important for early case detection, 
our search showed little evidence comparing disease and 
demographic characteristics between individuals diagnosed 
through active versus passive case-finding. We also searched 
PubMed, Google Scholar, Web of Science, and Embase for 
studies investigating the relation between tuberculosis and sex. 
Search terms included, but were not restricted to, 
“tuberculosis”, “contact tracing”, “contact investigation”, 
“active case-finding”, “sex”, “prevalence”, and “passive 
case-finding”. We did not restrict this search by language. 
This search retrieved a systematic review characterising sex 
differences in tuberculosis burden in countries of low and 
middle income. A significantly higher prevalence of tuberculosis 
was reported in men, and findings suggested that men are 
disadvantaged in accessing tuberculosis care in many settings. 
In Latin America, although case notifications are higher in men, 
two small prevalence surveys have shown a similar tuberculosis 
burden among men and women. Furthermore, our research 
group—IFHAD (Innovation For Health And Development)—has 
previously described a longer tuberculosis diagnostic delay 
among women and a perception that in our setting, Peru, 
women’s health is generally perceived to have lower priority 
than men’s, acting as a barrier to accessing health care. Taken 
together, these observations suggest that there could be a large 
burden of undiagnosed tuberculosis in women in our setting.
Added value of this study
In our prospective cohort study, we showed a very high risk for 
tuberculosis that persisted for at least 10 years among contacts 
aged 15 years or older of patients with laboratory-confirmed 
tuberculosis. Active case-finding made an important 
contribution to tuberculosis diagnoses in this group, and 
intensified active case-finding with repeat household visits and 
sputum culture testing detected more cases than did 
programmatic active case-finding, which relied on contacts to 
visit health posts for sputum smear microscopy. Active 
case-finding was equitable and, compared with passive 
case-finding, detected tuberculosis earlier and when contacts 
were less likely to have highly infectious sputum smear-positive 
tuberculosis. Importantly, active case-finding detected a large 
burden of undetected tuberculosis among women, reversing 
the apparent sex difference in tuberculosis case notifications. 
Despite the important contribution active case-finding made to 
tuberculosis diagnoses, during 10 years of follow up, passive 
case-finding was used to identify most of the tuberculosis case 
burden among contacts.
Implications of all the available evidence
Adult contacts of patients with tuberculosis should be a priority 
group for tuberculosis screening, preventive treatment, 
and long-term surveillance. Active case-finding interventions can 
make an important contribution to diagnosing tuberculosis 
among these contacts and might be improved by more intensive 
frequent testing, using more sensitive and rapid diagnostics and 
more relaxed symptomatic criteria for screening. However, 
such interventions should also be integrated with initiatives to 
concurrently improve access to, and quality of, passive 
case-finding. In our setting, active case-finding was equitable, 
detected tuberculosis at an earlier and less infectious stage, 
and showed a high burden of undetected tuberculosis in women, 
suggesting the apparent sex differences in tuberculosis case 
notifications in Peru might, at least in part, be accounted for by 
underdetection of tuberculosis in women.
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for secondary tuberculosis among the same contacts 
included in this study.4
Index patients were defined as patients registered 
to receive treatment in Peruvian Ministry of Health 
(MINSA)­run health posts who had laboratory­
confirmed pulmonary tuberculosis, which in this 
setting almost always implied a positive result on 
sputum smear micro scopy. Index patients were the first 
indi vidual we iden tified with tuberculosis among 
household members and they were eligible for 
inclusion in this study if they had at least one contact 
aged 15 years or older. They were not invited to 
participate if they had been previously recruited or were 
a contact of a patient whom we had already recruited, 
so households were only invited to participate once.
Contacts were defined as individuals aged 15 years or 
older who reported being in the same house as the index 
patient for more than 6 h per week in the 2 weeks 
preceding the index patient’s diagnosis. Contacts were 
ineligible if they were taking or awaiting tuberculosis 
treatment at the time of recruitment. During the study 
period, contacts aged 15 years or older were not routinely 
offered isoniazid preventive treatment, in accordance 
with national policy at the time.12 We restricted our 
investi gation to contacts aged 15 years or older because, 
in this setting, younger contacts might receive preventive 
treatment and are often treated for tuberculosis em piric­
ally, confounding interpretation of tuberculosis diagnosis 
in children. 
We obtained written informed assent or consent for 
all recruited contacts and index patients. Ethics approval 
for the study was obtained from the Callao Ministry of 
Health (Peru), the Asociación Benéfica PRISMA (Peru), 
and Imperial College London (UK). The study was done 
with the approval and collaboration of the Peruvian 
national tuberculosis programme.
Procedures
Study research nurses worked in collaboration with 
health posts to recruit index patients when they were 
diagnosed with tuberculosis. Index patients were invited 
to give a sputum sample, which was tested by smear 
microscopy and the microscopic­observation drug­
susceptibility (MODS) assay including liquid and solid 
Lowenstein­Jensen culture.13 Study nurses then visited 
the index patient’s household and completed a census 
of all contacts. Contacts were invited to participate in a 
randomised controlled trial of micronutrient supplemen­
tation to prevent tuberculosis.14 Because micronutrient 
supplementation was shown not to affect tuberculosis 
rates,14 contacts are included in our study irrespective 
of allocation. All index patients and contacts recruited 
com pleted a baseline questionnaire characterising demo­
graphics, socioeconomic factors, and other tuberculosis 
risk factors.4
All contacts were followed up for tuberculosis diagnosis 
by checking national tuberculosis programme treatment 
registers and cards in participating MINSA­run health 
posts. On diagnosis, and at subsequent household visits, 
we characterised tuberculosis episodes among contacts, 
including asking about symptom duration, and we asked 
about both extrapulmonary and pulmonary tuberculosis 
diagnosed and treated outside the jurisdiction of the health 
posts in Ventanilla. Self­reported tuberculosis episodes 
were confirmed against treatment registers in partici­
pating MINSA­run health posts whenever possible.
Outcomes
The primary outcome of our cohort study was tubercu­
losis diagnosis among contacts. Time to tuberculosis was 
defined from the date the index patient initiated tubercu­
losis treatment until the date the contact was diagnosed 
with tuberculosis, or if this date was unavailable, the date 
they initiated treatment. For contacts not diagnosed with 
tuberculosis, follow­up was censored at the date they 
were last known to be alive and free of tuberculosis. 
All partici pating contacts underwent integrated program­
matic active case­finding, intensified study active case­
finding, and programmatic passive case­finding. Any 
case of tuberculosis ascertained through one of these 
three strategies was considered an incident case in the 
follow­up period.
Programmatic active case-finding
During the study, MINSA recommended active case­
finding for contacts, which principally entailed clinical 
assessment and sputum smear microscopy without cul­
ture testing. Peruvian national guidelines recom mended 
collecting two spot samples from contacts with cough 
for longer than 2 weeks, although in practice one or 
two sputum samples were typically obtained from all 
contacts, irrespective of symptoms.12 Chest radiography 
was not recommended and only rarely done for contacts 
at the discretion of the assessing doctor. All contacts were 
eligible for this programmatic active case­finding, which 
(except for chest radiography) was provided free of direct 
charges at participating MINSA­run health posts. This 
programmatic active case­finding was not influenced by 
our study.
Intensified study active case-finding
Study research nurses visited households at recruitment 
then again after 2 weeks, 4 weeks, 6 weeks, and 8 weeks, 
and then every 4 weeks throughout the index patient’s 
treat ment (usually for 6 months but could be longer for 
patients with multidrug­resistant tuberculosis). During 
these visits, study nurses offered active case­finding 
to all participating contacts. This entailed offering free 
sputum testing for contacts who had any symptom 
suggestive of tuberculosis—ie, cough of any duration 
and type (whether productive or not), fever, night 
sweats, weight loss, or chest pain. Spot sputum samples 
were obtained with careful instruction in the privacy 
of the contact’s own home.15 The sample provided 
Articles
522 www.thelancet.com/infection   Vol 19   May 2019
(whether it appeared macroscopically to be sputum or 
saliva) was tested by smear microscopy and cultured 
using the MODS assay. After completion of the index 
patient’s treatment, we visited households on three 
occasions, approximately every 4 years. At these visits, 
we offered all available contacts free sputum testing 
with smear microscopy and culture using the thin­layer 
agar MDR/XDR­TB Colour Test.16 At the first two visits, 
testing was offered only to contacts who had symptoms. 
At the final visit, testing was offered to all contacts. If a 
contact was not present at the time of an active case­
finding visit, another household member completed 
the screening questions on behalf of the absent contact 
and sputum pots were left with instructions and 
collected 24 h later.
Programmatic passive case-finding
Throughout the follow­up period, contacts had access to 
passive case­finding at MINSA­run health posts, free of 
direct charges, both inside and outside the study area. 
The main diagnostic test available for tuberculosis 
during the study period was (and remains) smear 
microscopy of sputum, usually obtained with little 
instruction. Chest radiography was done at the contact’s 
expense and was interpreted by the consulting doctor 
and rarely by a radiologist. Investigation for tuberculosis 
was typically initiated among individuals presenting to 
health posts with cough for longer than 2 weeks.12 
Tuberculosis in this setting was also diagnosed and 
treated in MINSA­run hospitals, employer­insured health 
facilities for people with formal employment, prisons, 
and private clinics.
Statistical analysis
Continuous data were examined for normality and 
summarised by medians and IQRs because they were 
skewed. Continuous data were compared using the 
Figure 1: Study profile
715 index patients recruited
17 diagnosed through 
 programmatic
 active case-finding
36 diagnosed through 
 intensified study
 active case-finding
179 diagnosed through 
 programmatic passive
 case-finding by the 
 Ministry of Health and 
 other health facilities
2434 not diagnosed
   with tuberculosis
232 diagnosed with
 tuberculosis
53 diagnosed by active case-finding
2681 contacts identified
2666 contacts followed up
  for tuberculosis
15 excluded because they were 
 receiving tuberculosis treatment
Total
Contacts (n=2666)
Age at recruitment (years) 29 (21–42)
Male 1237 (46%)
Female 1429 (54%)
Known to have HIV infection 4 (<1%)
Index patients (n=715)
Age at recruitment (years) 27 (20–36)
Male 425 (59%)
Female 290 (41%)
Sputum smear status
Negative 16 (2%)
Positive, grade 1 253 (35%)
Positive, grade 2 210 (29%)
Positive, grade 3 236 (33%)
Drug susceptibility
Sensitive 581 (81%)
Isoniazid monoresistant 59 (8%)
Multidrug resistant* 75 (11%)
Household (n=715)
Principally cook with kerosene or solid cooking 
fuels (wood, coal, animal dung, or crop wastes)
258 (36%)
Wall material
Adobe 77 (11%)
Wood 344 (48%)
Cement or brick 294 (41%)
Floor material
Dirt 258 (36%)
Cement 415 (58%)
Tiles or laminated 42 (6%)
Access to piped water inside the house 327 (46%)
Access to a toilet inside the house 297 (42%)
Electric lighting 662 (93%)
Asset ownership
Television 649 (91%)
Stove 696 (97%)
Fridge 319 (45%)
Head of household did not complete secondary 
education
429 (60%)
Rooms in the household 3 (2–3)
People sleeping in the household 5 (4–6)
Crowding (more than two people sleeping 
per room)
268 (37%)
Monthly household income (US$)† 153 (98–214)
Data are median (IQR) or n (%). Missing data were imputed using the median value 
because no variables had more than 5% of data missing. *Multidrug-resistant 
tuberculosis was defined in patients initially prescribed a multidrug-resistant 
tuberculosis treatment regimen or who had microbiological evidence of resistance 
to rifampicin and isoniazid. †Data were obtained in Peruvian Soles (PEN) and 
converted to US$ using the exchange rate US$1=PEN3·27 (July 13, 2018). 
Table: Baseline characteristics of contacts, index patients, and households
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Mann­Whitney U test. Categorical data were summarised 
as proportions and compared using the two­sample 
proportion test. Because missing data were infrequent, 
occurring in fewer than 5% of cases for baseline 
characteristics, the median value was used to complete 
baseline data. For every year after initiation of the index 
patients’ treatment, we calculated tuberculosis incidence 
per 100 person­years and generated 95% CIs based on 
the Poisson distribution. We plotted these data against 
community tuberculosis incidence, which was calculated 
using the average tuberculosis case notification rate 
among adults aged 15 years or older in Ventanilla 
between 2002 and 2014, adjusted by 20% to correct for 
under diagnosis and reporting because this value is the 
esti mated case detection gap in Peru.7 We compared 
tuberculosis incidence between male and female contacts 
by calculating incidence rate ratios (IRRs) using the Stata 
command stir. We derived and plotted Kaplan­Meier 
curves to calculate cumulative tuberculosis risk over time.
The 6­monthly rolling average and cumulative pro­
portion of contacts diagnosed with tuberculosis were 
plotted by tuberculosis ascertainment strategy and com­
pared overall and at the end of 6 months because this 
time was when both programmatic and intensified study 
active case­finding were principally implemented. To 
elucidate sex differences in tuberculosis diagnosis by 
ascertainment strategy, we compared the proportion of 
people who were female between contacts diagnosed 
through both programmatic and intensified study active 
case­finding (referred to collectively as all active case­
finding), contacts diagnosed through programmatic 
passive case­finding, index patients (who had been 
princi pally diagnosed through programmatic passive 
case­finding), the national proportion of new cases 
notified in 2015, and regional and global incidence data.2,7 
We compared overall symptom duration before diagnosis 
between contacts diagnosed through all active case­
finding versus programmatic passive case­finding for 
contacts with data available and plotted the pro portion of 
contacts who had symptoms for fewer than 15 days, 
30 days, 60 days, and 90 days, to show differ ences at 
relevant thresholds of symptom duration. Finally, we 
compared sputum smear grade and treat ment success 
(defined as cured or completed treatment, according 
to national treatment registers) proportions between 
contacts diagnosed through all active case­finding 
versus programmatic passive case­finding. To assess the 
socioeconomic equity of active case­finding, we compared 
household secondary education and house hold income 
between contacts diagnosed through all active case­
finding versus programmatic passive case­finding.
All analyses were done using Stata (version 13). p values 
were two­sided with significance assessed at the 5% level. 
Role of the funding source
The funders had no role in study design, data collection, 
data analysis, data interpretation, or writing of the report. 
The corresponding author had full access to all the data 
in the study and had final responsibility for the decision 
to submit for publication.
Figure 2: Cumulative risk and incidence of tuberculosis among contacts
Error bars represent 95% CIs.
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Results
Between Oct 23, 2002, and May 26, 2006, 715 index 
patients were diagnosed with tubercu losis through 
programmatic passive case­finding and were recruited 
(figure 1). The median age of index patients was 27 years 
(IQR 20–36). 290 (41%) index patients were female (table). 
2681 contacts of index patients were assessed for study 
eligibility, of whom 15 (ten males and five females) 
were excluded because they were taking or awaiting 
tuberculosis treatment. The study population therefore 
included 2666 contacts. The median age of contacts at 
recruitment was 29 years (IQR 21–42). 1429 (54%) contacts 
were female and 1237 (46%) were male. Contacts were 
followed up until March 1, 2016. Follow­up was for a total 
of 23 758 person­years, with female contacts followed up 
for 13 047 person­years and male contacts for 10 711 person­
years. Median follow up was 10·0 years per contact 
(IQR 7·5–11·0). During follow­up, 80 (3%) contacts died.
232 (9%) contacts were diagnosed with tuberculosis 
during the follow­up period, of whom 121 (52%) were 
female and 111 (48%) male. The 2­year cumulative risk of 
tuberculosis was 4·6% (95% CI 3·5–5·5; figure 2A). 
The overall incidence of tuberculosis was 0·98 cases 
(95% CI 0·86–1·10) per 100 person­years. Incidence of 
tubercu losis in female contacts was 0·93 cases per 
100 person­years and in male contacts was 1·00 cases per 
100 person­years. Tuberculosis incidence did not differ 
between male and female contacts (IRR 1·10, 95% CI 
0·86–1·50; p=0·4; appendix). Overall incidence of 
tuberculosis was highest during the first 3 years after the 
index patient initiated treatment and remained higher 
than the estimated community incidence throughout the 
duration of follow­up (figure 2B).
Of 232 contacts diagnosed with tuberculosis, 53 (23%) 
were diagnosed through all active case­finding (figure 1): 
17 (7%) contacts were diagnosed by programmatic active 
case­finding and 36 (16%) by intensified study active 
case­finding. The remaining 179 (77%) contacts were 
diagnosed through programmatic passive case­finding: 
158 (88%) were diagnosed by MINSA­run health posts 
and hospitals and 21 (12% ) by health institutions outside 
of MINSA. 196 (84%) of 232 diagnoses were confirmed 
by checking official records. During the first 6 months 
after the index patient initiated treatment, 51 (22%) of 
232 contacts were diagnosed with tuberculosis. Of these, 
23 (45%) were diagnosed through all active case­finding 
and 28 (55%) were diagnosed through programmatic 
passive case­finding. Figure 3 shows 6­monthly rolling 
average and cumulative proportions of contacts with 
tubercu losis, by ascertainment strategy. The number of 
tubercu losis tests done during intensified study active 
case­finding is in the appendix.
Contacts diagnosed through all active case­finding were 
more likely to be female than were index patients (36 [68%] 
of 53 vs 290 [41%] of 715; p=0·0001; figure 4). 12 (71%) of 
17 contacts diagnosed through programmatic active case­
finding and 24 (67%) of 36 contacts diagnosed through 
intensified study active case­finding were female. 85 (47%) 
of 179 contacts diagnosed through programmatic passive 
case­finding were female. Contacts diagnosed through all 
active case­finding were significantly more likely to be 
female than were contacts diagnosed through program­
matic passive case­finding (p=0·009).
Overall, contacts diagnosed through all active case­
finding had a significantly shorter symptom duration 
before diagnosis than did contacts diagnosed through 
passive case­finding (p=0·03; figure 5). The median 
symp tom duration for contacts with data available (n=163) 
was 30 days (IQR 30–45) for those diagnosed through 
programmatic active case­finding, 22 days (10–40) for 
those diagnosed through intensified study active case­
finding, and 32 days (20–60) for those diagnosed through 
programmatic passive case­finding. Of 36 contacts diag­
nosed through all active case­finding, 17 (47%) had 
symptoms for less than 30 days compared with 37 (29%) 
of 127 contacts diagnosed through programmatic passive 
case­finding. Nine (25%) of 36 contacts diagnosed 
Figure 3: 6-monthly rolling average number and cumulative proportion of contacts diagnosed with 
tuberculosis, by tuberculosis ascertainment strategy
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through all active case­finding had symptoms for less 
than 15 days compared with ten (8%) of 127 contacts 
diagnosed through programmatic passive case­finding.
Figure 6 shows the distribution of laboratory results for 
contacts. Overall, 33 (62%) of 53 contacts diagnosed 
through all active case­finding had sputum smear­negative 
tuberculosis compared with 62 (35%) of 179 contacts 
diagnosed through programmatic passive case­finding 
(p=0·0003). This difference remained significant when 
considering only contacts with a sputum smear result 
available, and only contacts who had laboratory­confirmed 
tuber culosis (appen dix). Of 36 contacts diagnosed through 
intensified study active case­finding, 29 (81%) had 
sputum smear­negative (culture­positive) tuberculosis. 
The proportion of contacts who had successful tuber­
culosis treatment did not differ between contacts 
diagnosed through all active case­finding and those 
diagnosed through programmatic passive case­finding 
(38 [72%] of 53 vs 131 [73%] of 179; p=0·8).
The proportion of households in which the head of the 
household had not completed secondary education did 
not differ between contacts diagnosed through all active 
case­finding and those diagnosed through passive case­
finding (40 [75%] of 53 vs 123 [69%] of 179; p=0·3). 
Household income did not differ between contacts 
diagnosed through all active case­finding compared with 
those diagnosed through passive case­finding (median 
income US$153 [IQR 122–248] vs US$153 [92–248]; 
p=0·1).
Discussion
Our prospective cohort study of 2666 contacts aged 
15 years or older provides important evidence to support 
and optimise the early implementation of active case­
finding among contacts of patients with tuberculosis in 
countries of low and middle income. Active case­finding 
detected a substantial tuberculosis burden among this 
group, accounting for nearly half of all cases diagnosed 
in the first 6 months after index patient diagnosis. 
Intensified study active case­finding (repeated household 
visits with culture testing) detected more tuberculosis 
cases than did programmatic active case­finding (relying 
on contacts to visit health posts for sputum smear 
microscopy). Compared with passive case­finding, active 
case­finding was equitable and detected tuberculosis 
earlier and when contacts were less likely to have highly 
infectious, sputum smear­positive tuberculosis. Further­
more, in this setting, active case­finding detected 
tuberculosis in a higher proportion of women than men, 
providing evidence to support our hypothesis that higher 
tuberculosis case notifications in men in Peru could 
reflect a health­care disparity, with passive case­finding 
failing to adequately detect tuberculosis in women. 
Despite these findings, passive case­finding detected 
most of the tuberculosis case burden among contacts, 
showing the importance of improving both access to, and 
quality of, passive case­finding for both men and women.
We found a substantial burden of tuberculosis through 
active case­finding, extending evidence from a cluster­
randomised trial that showed the effectiveness of active 
case­finding among contacts using repeated chest 
radiography and sputum culture testing for increasing 
tuberculosis case detection.17 We cannot ascertain how 
often active case­finding accelerated detection of 
tuberculosis that would have later been diagnosed 
through passive case­finding nor how active case­finding 
detected cases that would never have been diagnosed 
through passive case­finding—eg, because they would 
have resolved, died, or remained chronically undetected. 
However, intensified study active case­finding mainly 
occurred after programmatic active case­finding and 
detected more cases than did programmatic active case­
finding, thus adding considerably to the overall diagnostic 
yield. Early diagnosis and initiation of appropriate 
treatment rapidly renders patients with tuberculosis non­
infectious, averting further transmission.18 Concordantly, 
mathematical models suggest that active case­finding 
Figure 4: Proportion of people with tuberculosis who were female, by tuberculosis ascertainment strategy
Global and Latin American data were derived from the estimated tuberculosis incidence among people aged 
15 years or older, reported by WHO.2 Peruvian data were derived from routinely available data.7 p values indicate 
two-sample proportion tests. Dotted line at 50% acts as a visual guide to show differences between groups. 
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and treatment of subclinical tuberculosis should have a 
greater effect towards tuberculosis elimination than 
would increasing passive case­finding.19 Our data support 
these projections because we found that contacts 
diagnosed through active case­finding had a shorter 
symptom duration before diagnosis and, on diagnosis, 
were more likely to have sputum smear­negative 
tuberculosis. Taken together, our results suggest that 
additional case­finding efforts—using more sensitive 
and rapid diagnostics (potentially including molecular 
tests) and more relaxed symptomatic criteria for 
tuberculosis testing among people with known recent 
tuberculosis exposure—are likely to be vital to the early 
detection and treatment of tuberculosis in high­burden 
settings.
Our results suggest that some of the observed sex 
differences in tuberculosis burden in Peru could be 
attributable to disparities in access to care under 
program matic passive case­finding, and not just 
differences between the sexes in exposure and 
susceptibility to tubercu losis. The globally observed 
predominance of tubercu losis among men has been 
attributed to increased exposure20 or amplified 
susceptibility because of factors including larger lung 
volumes, sex hormones, and higher hepcidin levels.21,22 In 
our study, variation of tuberculosis exposure by sex was 
minimised by studying household contacts of patients 
with infectious tuberculosis. In this population, we 
found that women were as likely as men to develop 
tuberculosis. In other settings, high HIV prevalence is 
driving an increased tuberculosis burden among 
women,23 but this situation is unlikely in our setting 
where population HIV prevalence is low (approximately 
0·2% of women aged 15–49 years) and only four contacts 
were known to have HIV.7,24 Other explanations for 
globally higher tuberculosis case notifi cations among 
men are that men might have better access to health care 
or provide better quality sputum for tuberculosis 
diagnosis.25 We found that both intensified study and 
programmatic active case­finding diagnosed tuberculosis 
in significantly more women than men, showing a large 
burden of undetected tuberculosis among women that 
was overcome by active case­finding. Interpretation of 
this finding is complex because slightly more contacts 
were women, and women who might have had more 
intense exposures to predominantly male index patients, 
but it is supported by a previous study of contacts in Peru 
in which women were also significantly more likely to be 
diagnosed by active case­finding than men.26 
Peruvian society is known for being particularly 
patriarchal, reflected by our previous work showing longer 
diagnostic delay among women,10 and places greater 
community emphasis on men’s health, with women’s 
health considered to be of lower priority.11 Our results 
suggest that instructed sputum collection in the privacy of 
the contact’s own home, and perseverance with repeated 
opportunities for testing, overcame this sex bias of 
Figure 5: Total symptom duration before diagnosis among contacts with tuberculosis with data available, 
by tuberculosis ascertainment strategy
p value calculated with the Mann-Whitney U test and compares total symptom duration between the two tuberculosis 
ascertainment strategies. 
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prioritisation of men’s health and provided better access 
for women than did passive case­finding.15 This result is 
important because it shows the potential of active case­
finding interventions to provide health­care equity for 
hard­to­reach underserved groups. These results could 
also be partly accounted for by men being less likely to 
access active case­finding if they were less often present 
during household visits, a hypothesis supported by global 
data indicating that men are less likely to participate in 
prevalence surveys.6 We do not believe this possibility to 
be the case in our study, because if men were not present 
during household visits, another household member was 
able to complete the screening interview on their behalf 
and sputum pots were left to facilitate sputum collection 
at the contact’s convenience. Overall, these complexities 
highlight the importance of further research to investigate 
equitable strategies to optimise access to tuberculosis 
testing in both active case­finding and passive case­finding 
strategies for members of both sexes.
A further novel finding of this study is that passive 
case­finding accounted for most of the overall tubercu­
losis burden among contacts. This could in part be 
because passive case­finding continued for a median of 
10 years whereas active case­finding was principally 
implemented during the first 6 months and then only 
once every 4 years. However, even during the first 
6 months, passive case­finding diagnosed more tubercu­
losis than did active case­finding. This finding is some­
what surprising and could partly be accounted for by a 
spillover effect if active case­finding made contacts more 
aware of tuberculosis symptoms and signs and how 
to access free tuberculosis testing. Thus, even if a diag­
nosis was missed by active case­finding or tuberculosis 
developed afterwards, active case­finding activities might 
have directly increased subsequent uptake of passive 
case­finding, highlighting the potential of education as a 
core component of any active case­finding strategy 
to increase access to passive case­finding.27 It is worth 
further noting that visiting households at 4­yearly inter­
vals to offer rescreening only detected a few additional 
cases. In summary, these findings support the idea 
that active case­finding might need to be done more 
frequently among contacts, particularly during the first 
3 years after exposure, when incidence is highest, to 
detect more cases at an earlier stage.
Finally, our results characterising the tuberculosis 
burden among contacts extend those presented in a 
systematic review and show an overall tuberculosis risk 
of approximately 5% during the first 2 years after 
exposure.28 We showed that, in this setting, the incidence 
of tuberculosis among contacts is highest in the first 
3 years after exposure and remains higher than the 
background incidence for at least 10 years, longer than 
previously shown and indicative of the urgent need 
to expand the use of preventive treatment for this 
population, which accounts for many millions of people 
globally. This persistent risk could be accounted for by a 
combination of late reactivation of latent tuberculosis 
infection, reinfection due to ongoing community trans­
mission, and clustering of socioeconomic risk factors 
within tuberculosis­affected households.
A strength of our study is the comprehensive follow­up 
to ascertain tuberculosis diagnoses both within the study 
area at participating MINSA­run health posts using 
treatment registers and outside of the study area by 
asking about tuberculosis episodes at other health posts, 
private clinics, and employer­insured health facilities. 
Our study also has limitations. Intensified study active 
case­finding did not include chest radiography, thus, it 
was unable to diagnose tuberculosis in people without 
symptoms who had radiological signs suggestive of 
tuberculosis. Although we reported treatment success 
proportions that are consistent with previous research in 
this setting,27 we were unable to identify people who were 
diagnosed with tuberculosis through passive case­finding 
but who never started treatment, because these people 
are rarely recorded in national treatment registers. 
Furthermore, much larger studies are needed to investi­
gate the effect of active case­finding on long­term 
tubercu losis treatment outcomes, including recurrence 
and disability. Because active case­finding among con­
tacts aims to diagnose all cases of tuberculosis irrespect­
ive of the primary source of infection, we did not use 
molecular techniques to identify tuberculosis strains and 
confirm transmission from index patients to contacts 
because it would not affect our conclusions. Finally, we 
did not gather data for costs associated with the 
intensified study active case­finding described. However, 
active case­finding has been shown to be both feasible 
and cost­effective in various settings29 and, integrated 
with preventive treatment for contacts, is likely to have 
an important effect on tuberculosis incidence, making it 
worth further investment.30
Despite widespread implementation in high­income 
countries, active case­finding among contacts is infre­
quently implemented and accessed in countries of low and 
middle income. Our study shows the important contribution 
active case­finding can make to diagnosing tuberculosis 
among contacts and suggests that more intensified active 
case­finding, including using more sensitive diagnostics, 
has the potential to find more tubercu losis cases. Active 
case­finding was equitable, diag nosed tuberculosis at an 
earlier and usually less infectious stage, and showed a 
high burden of undetected tuberculosis among women, 
reversing apparent sex differences in tuberculosis 
notifications in this setting.
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